ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $6,000 | – | 373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clal Insurance Enterprises Holdings Ltd | 4,306 | $585,000,000 | 0.63% |
| DAFNA Capital Management LLC | 205,825 | $1,515,000 | 0.52% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $15,413,000 | 0.37% |
| Altshuler Shaham Ltd | 1,095,018 | $8,060,000 | 0.23% |
| MEITAV INVESTMENT HOUSE LTD | 338,655 | $2,493,000 | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 125,900 | $927,000 | 0.01% |
| HRT FINANCIAL LP | 23,214 | $170,000 | 0.01% |
| Squarepoint Ops LLC | 63,736 | $469,000 | 0.00% |
| Paloma Partners Management Co | 16,318 | $120,000 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 152,932 | $1,126,000 | 0.00% |